Molecular properties of CD133+ glioblastoma stem cells derived from treatment-refractory recurrent brain tumors
Open Access
- 26 May 2009
- journal article
- other
- Published by Springer Science and Business Media LLC in Journal of Neuro-Oncology
- Vol. 94 (1), 1-19
- https://doi.org/10.1007/s11060-009-9919-z
Abstract
Glioblastoma multiforme (GBM) remains refractory to conventional therapy. CD133+ GBM cells have been recently isolated and characterized as chemo-/radio-resistant tumor-initiating cells and are hypothesized to be responsible for post-treatment recurrence. In order to explore the molecular properties of tumorigenic CD133+ GBM cells that resist treatment, we isolated CD133+ GBM cells from tumors that are recurrent and have previously received chemo-/radio-therapy. We found that the purified CD133+ GBM cells sorted from the CD133+ GBM spheres express SOX2 and CD44 and are capable of clonal self-renewal and dividing to produce fast-growing CD133− progeny, which form the major cell population within GBM spheres. Intracranial injection of purified CD133+, not CD133− GBM daughter cells, can lead to the development of YKL-40+ infiltrating tumors that display hypervascularity and pseudopalisading necrosis-like features in mouse brain. The molecular profile of purified CD133+ GBM cells revealed characteristics of neuroectoderm-like cells, expressing both radial glial and neural crest cell developmental genes, and portraying a slow-growing, non-differentiated, polarized/migratory, astrogliogenic, and chondrogenic phenotype. These data suggest that at least a subset of treated and recurrent GBM tumors may be seeded by CD133+ GBM cells with neural and mesenchymal properties. The data also imply that CD133+ GBM cells may be clinically indolent/quiescent prior to undergoing proliferative cell division (PCD) to produce CD133− GBM effector progeny. Identifying intrinsic and extrinsic cues, which promote CD133+ GBM cell self-renewal and PCD to support ongoing tumor regeneration may highlight novel therapeutic strategies to greatly diminish the recurrence rate of GBM.Keywords
This publication has 73 references indexed in Scilit:
- Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacityProceedings of the National Academy of Sciences of the United States of America, 2008
- Control of the Reversibility of Cellular Quiescence by the Transcriptional Repressor HES1Science, 2008
- Inhibitor of differentiation 4 drives brain tumor-initiating cell genesis through cyclin E and notch signalingGenes & Development, 2008
- Drosophila neuroblast asymmetric divisions: cell cycle regulators, asymmetric protein localization, and tumorigenesisThe Journal of cell biology, 2008
- Identification of stem cells in small intestine and colon by marker gene Lgr5Nature, 2007
- FABP7 expression in glioblastomas: relation to prognosis, invasion and EGFR statusJournal of Neuro-Oncology, 2007
- The Homeobox Gene GAX Activates p21WAF1/CIP1 Expression in Vascular Endothelial Cells through Direct Interaction with Upstream AT-rich SequencesPublished by Elsevier BV ,2007
- Glioma stem cells promote radioresistance by preferential activation of the DNA damage responseNature, 2006
- Regulation of human neural precursor cells by laminin and integrinsJournal of Neuroscience Research, 2006
- Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cellNature Medicine, 1997